Found 6 clinical trials
Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease
This Parkinson disease (PD) trial will test whether 26 months of citalopram, compared to placebo, can alter the build-up of toxic amyloid-beta plaques in the visuospatial cortex of the brain
- 0 views
- 19 Apr, 2022
- 1 location
Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder
The purpose of this study is to determine if Liposom Forte will enhance the response to antidepressant therapy with citalopram in elderly patients suffering from Major Depressive Disorder (MDD
- 0 views
- 02 Aug, 2021
- 16 locations
Brain Response to Serotonergic Medications in ASD
This study investigates brain response to single acute dose of citalopram, tianeptine, and placebo in males with and without autism spectrum disorder.
- 97 views
- 06 May, 2022
- 1 location
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD) (DOTS-AD)
Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram, followed by double-blind, randomized adjunctive treatment with clonazepam or pregabalin for persistent symptoms.
- 420 views
- 26 Mar, 2022
- 1 location
Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder
One-third of the patients with major depressive disorder do not respond to conventional antidepressants that act through the mono-aminergic system. The available treatment modalities, including SSRIs, are slow to act and have a lag time before showing improvement in symptoms of patients. To overcome these treatment hurdles, add-on therapy to …
- 0 views
- 06 Nov, 2021
- 1 location
First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic (FIAT)
serotonin reuptake inhibitors (SSRI), e.g. citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, in depression with anxiety and insomnia is preferable trazodone and in severer disorders
- 0 views
- 10 Apr, 2022